Article Versions Notes

Koseki T, Hamano H, Hatano M, Tobe T, Ieda R, Nakai T, Zamami Y, Yamada S. Fractures Associated with Immune Checkpoint Inhibitors: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database. Pharmaceuticals. 2025; 18(3):333. https://doi.org/10.3390/ph18030333

Koseki, Takenao, Hirofumi Hamano, Masakazu Hatano, Takao Tobe, Ryo Ieda, Tsuyoshi Nakai, Yoshito Zamami, and Shigeki Yamada. 2025. "Fractures Associated with Immune Checkpoint Inhibitors: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database" Pharmaceuticals 18, no. 3: 333. https://doi.org/10.3390/ph18030333

Koseki, T., Hamano, H., Hatano, M., Tobe, T., Ieda, R., Nakai, T., Zamami, Y., & Yamada, S. (2025). Fractures Associated with Immune Checkpoint Inhibitors: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database. Pharmaceuticals, 18(3), 333. https://doi.org/10.3390/ph18030333